Detail about Aster DM Healthcare
The company was incorporated on January 18, 2008, as ‘ DM Healthcare Private Limited ’ at Kochi, Ernakulam, Kerala as a private limited company under the Companies Act, 1956. The name of the company was changed to ‘ Aster DM Healthcare Private Limited ’ and a fresh instrument of objectification consequent upon the change of name was issued on November 29, 2013. latterly, the company was converted into a public company pursuant to a special resolution passed by shareholders on November 10, 2014, and the name of the company was changed to ‘ Aster DM Healthcare Limited ’ a Fresh Certificate of Incorporation consequent upon conversion to public limited Company dated on January 1, 2015.
The company is one of the largest private healthcare service providers which operates in multiple GCC countries grounded on figures from hospitals and conventions. It presently operates in all of the GCC countries, which comprise the United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait, Bahrain, Jordan, India, and the Philippines. Its GCC operations are headquartered in Dubai, the United Arab Emirates, and Indian operations are headquartered in Kochi, Kerala. The company has a diversified portfolio of healthcare installations, conforming of 9 hospitals, 90 conventions, and 206 retail apothecaries in the GCC countries, 10multi-specialty hospitals and 7 conventions in India, and 1 clinic in the Philippines as of September 30, 2017.
The business area of the company
The company operates in multiple parts of the healthcare assiduity, including hospitals, conventions, and retail apothecaries, and gives healthcare services to cases across profitable parts in several GCC states through its colorful brands “ Aster ”, “ Medicare ” and “ Access ”. The maturity of its hospitals and conventions gives secondary and tertiary healthcare services to cases. In addition to furnishing core medical, surgical, and exigency services, some of its hospitals give complex and advanced quaternary healthcare in colorful specialties, including cardiology, oncology, radiology, ophthalmology, neurosciences, pediatrics, gastroenterology, orthopedics, and critical care services.
Brands
These are the brands of Aster DM Healthcare.
MEDCARE
|
ACCESS
|
Medcity
|
MIMS
|
AADHAR HOSPITAL
|
PRIME HOSPITAL
|
|
|
|
|
Awards and achievements
- 2017 Aster CMI sanitarium has entered the ‘ CMO Asia Presents Asia Healthcare Excellence Award ’ in the ‘ stylish hospitality in healthcare ’ order.
- 2018 Aster DM Healthcare wins Special Recognition at Arabia CSR Awards 2018.
- 2018 Aster Pharmacy & Aster Hospital win Dubai Business Excellence Awards.
- 2019 Aster DM Healthcare wins four Dubai Business Excellence Awards.
- 2019 Aster Levies CSR Award PR.
- 2019 Aster DM Healthcare bags Gulf Business Awards- 2017 for the'' Healthcare Company of the Time'' order.
- 2020 Aster MIMS Kottakkal conferred Six Sigma Healthcare Excellence Award.
- 2020 Aster DM Healthcare wins 6 awards at AHPI Awards 2020
Peers
S.NO.
|
COMPANY
|
MCAP Cr.
|
P/B
|
P/E
|
EPSRs.
|
ROE%
|
EV/EBITDA
|
1
|
Apollo Hospital Ent.
|
61,380.95
|
9.53
|
72.8
|
58.64
|
10.12
|
38.38
|
2
|
Max Healthcare Inst
|
39,368.90
|
6.18
|
119.86
|
3.39
|
5.43
|
72.79
|
3
|
Dr. Lal Pathlabs
|
22,457.91
|
14.99
|
74.76
|
36.04
|
26.5
|
44.12
|
4
|
Fortis Healthcare
|
19,508.12
|
2.2
|
0
|
-0.25
|
-0.15
|
78.68
|
5
|
Narayana Hrudayalay
|
14,573.99
|
11.52
|
81.05
|
8.8
|
11.58
|
34.14
|
6
|
Aster DM Healthcare
|
12,737.58
|
4.28
|
99.92
|
2.55
|
3.11
|
47.8
|
7
|
Krishna Inst.Medi
|
11,205.09
|
7.84
|
44.06
|
31.78
|
24.37
|
27.75
|
8
|
Metropolis Health.
|
7,799.33
|
9.28
|
48.5
|
31.41
|
26.18
|
28.71
|
9
|
Vijaya Diagnostic
|
4,440.80
|
9.15
|
47.73
|
9.12
|
26.12
|
21.72
|
10
|
Thyrocare Tech.
|
3,638.68
|
6.77
|
29.43
|
23.36
|
31.68
|
18.38
|
11
|
Kovai Medical Center
|
1,633.46
|
2.58
|
17.6
|
84.84
|
18.63
|
7.58
|
12
|
Krsnaa Diagnostics
|
1,533.15
|
2.19
|
23.26
|
20.99
|
21
|
9.42
|
13
|
Shalby
|
1,370.10
|
1.48
|
20.63
|
6.15
|
7.95
|
9.36
|
14
|
KMC Speciality Hosp
|
1,000.53
|
10.77
|
41.51
|
1.48
|
31.61
|
24.82
|
15
|
Artemis Medicare
|
807.9
|
2.73
|
21.77
|
2.78
|
12.02
|
12.15
|
16
|
Indraprastha Medical
|
579.83
|
1.68
|
9.14
|
6.92
|
0.86
|
4.11
|
17
|
Dr Agarwals Eye Hsp
|
471.08
|
5.4
|
13.88
|
72.21
|
36.29
|
6.46
|
18
|
Kaya
|
448.1
|
6.39
|
0
|
-24.61
|
-26.71
|
33.22
|
19
|
Lotus Eye Hospital
|
146.61
|
2.62
|
32.22
|
2.19
|
5.56
|
15.25
|
20
|
Tejnaksh Healthcare
|
128.23
|
6.39
|
56.89
|
2.22
|
12.51
|
31.59
|
21
|
Fortis MalarHospital
|
105.8
|
1.41
|
0
|
-5.3
|
-10.09
|
10.12
|
22
|
Family Care Hospital
|
52.8
|
3.4
|
10.55
|
1.56
|
44.6
|
6.66
|
23
|
Aspira Pathlab&Diagn
|
46.32
|
3.7
|
21.31
|
2.11
|
42.26
|
10.67
|
24
|
Gian Life Care
|
26.99
|
1.48
|
6.17
|
4.23
|
23.33
|
3.9
|
25
|
NG Industries
|
26.15
|
1.06
|
8.38
|
9.31
|
13.41
|
5.79
|
26
|
Medinova Diagnostic
|
23.46
|
0
|
20.98
|
1.12
|
0
|
13.12
|
27
|
Transgene Biotek
|
23.41
|
0
|
0
|
-1.21
|
-105.59
|
-130.19
|
28
|
Choksi Lab
|
22.92
|
1.26
|
11.23
|
2.93
|
-13.74
|
5.49
|
29
|
Chennai Meena Multi
|
15.31
|
0
|
0
|
-0.14
|
0
|
11.59
|
30
|
Soni Medicare
|
12.79
|
3.17
|
0
|
-1.44
|
-11.71
|
24.42
|
31
|
Dr Lalchandani Labs
|
11.61
|
1.22
|
12.46
|
2.15
|
11.56
|
5.31
|
32
|
Looks Health Service
|
9.32
|
0.62
|
387.77
|
0.02
|
-1.15
|
47.99
|
33
|
Indo-Global Enter.
|
7.55
|
1.32
|
0
|
-0.5
|
-6.61
|
-62.82
|
34
|
DhanvantriJeevan Rek
|
6.26
|
0.66
|
18.68
|
0.82
|
-14.69
|
3.53
|
35
|
Constronics Infra
|
5.26
|
47.71
|
33.26
|
0.22
|
-138.75
|
50.21
|
36
|
Dolphin Medical Serv
|
2.6
|
0.25
|
0
|
-0.13
|
-2.93
|
-26.65
|
Strengths
- The company has shown a good profit growth of 23.33% over the past 3 years.
- The company has shown good revenue growth of 23.36% for the past 3 years.
- Company is virtually debt free.
- Company’s PEG ratio is 0.40.
- The company has an efficient Cash Conversion Cycle of -154.09 days.
- The company has good cash flow management; CFO/PAT stands at 2.75.
- The company has a strong degree of Operating leverage, Average Operating leverage stands at 28.46.
Limitations
- Company has had a poor ROE of 0.93% over the past 3 years.
- Company has a poor ROCE of 2.15% over the past 3 years
- Tax rate is low at -0.24.
- The company is trading at a high PE of 91.81.
- The company is trading at a high EV/EBITDA of 43.93.